TITLE

Necrotizing Pseudomonas chondritis after piercing of the upper ear

AUTHOR(S)
Lee, Todd C.; Gold, Wayne L.
PUB. DATE
April 2011
SOURCE
CMAJ: Canadian Medical Association Journal;4/19/2011, Vol. 183 Issue 7, p819
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents a case study of a 15-year-old girl who had necrotizing pseudomonas chondritis after the upper part of her left was pierced. It says that the antimicrobial treatment of the patient was changed from ciprofloxacin to piperacillin-tazobactam. It mentions that the bacterium Staphylococcus aureus was considered as the most frequent cause of skin infections due to piercing. It recommends various tips in preventing infection after piercing.
ACCESSION #
61404297

 

Related Articles

  • Selection of Oxacillin Resistance in Oxacillin-Sensitive Staphylococcus aureus through Exposure to Ciprofloxacin but not Piperacillin/Tazobactam. Evans, M. E. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2002, Vol. 21 Issue 8, p621 

    Ten oxacillin-sensitive Staphylococcus aureus strains were grown on agar containing four times their ciprofloxacin MIC to determine if exposure to ciprofloxacin would increase their resistance to oxacillin. All strains grew on the ciprofloxacin-containing agar and subsequently grew on...

  • Piperacillin/tazobactam.  // Reactions Weekly;8/22/2009, Issue 1266, p25 

    The article describes the case of a 56-year-old man who developed meticillin-resistant Staphylococcus aureus (MRSA) infection following administration of piperacillin/tazobactam. Particular focus is given to the medical history of the patient. It recommends screening of MRSA not only on...

  • Comparison of antimicrobial resistance pattern of hospital - and community - acquired Methicillin resistant Staphylococcus aureus. Basavaraj, C. Metri; Peerapur, B. V.; Jyothi, P. // Journal of Chemical & Pharmaceutical Research;2014, Vol. 6 Issue 9, p201 

    Methicillin-resistant Staphylococcus aureus (MRSA) is now considered to be a community, state, national and international problem. Patients and the public are increasingly seeing MRSA and rates of MRSA infections as indicators of the quality of patient care. The present study was done to compare...

  • Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data. Zelenitsky, Sheryl A.; Ariano, Robert E.; Zhanel, George G. // Journal of Antimicrobial Chemotherapy (JAC);Feb2011, Vol. 66 Issue 2, p343 

    Objectives To evaluate, using Monte Carlo simulation, the pharmacodynamics (PD) of empirical antibiotic monotherapies for serious infections consistent with Canadian intensive care unit (ICU) surveillance data. Methods Meropenem, piperacillin/tazobactam and cefepime, along with ceftobiprole, a...

  • Antibiotics: Synergistic MRSA combinations. Bush, Karen // Nature Chemical Biology;Nov2015, Vol. 11 Issue 11, p832 

    The article discusses the combination of three β-lactam molecules such as the meropenem, tazobactam, and piperacillin which kills methicillin resistant Staphylococcus aureus (MRSA) in a mouse model on a synergistic mechanism. Topics mentioned include the low produce of penicillin-binding...

  • CME Questions.  // Infectious Disease Alert;Jun2010, Vol. 29 Issue 9, p106 

    A quiz about the antibacterial drugs piperacillin and tazobactam is presented.

  • Piperacillin/tazobactam.  // Reactions Weekly;6/2/2012, Issue 1404, p33 

    The article describes the case of a 62-year-old man who developed Kounis syndrome while receiving treatment with piperacillin/tazobactam for pneumonia.

  • Piperacillin/tazobactam.  // Reactions Weekly;6/2/2012, Issue 1404, p34 

    The article offers information a case of linear immunoglobulin A (IgA) bullous dermatosis in an elderly patient after receiving Tazocin (piperacillin/tazobactam).

  • Piperacillin/tazobactam.  // Reactions Weekly;11/20/2010, Issue 1328, p36 

    The article describes a case of generalised non-convulsive status epilepticus (NCSE) in a 63-year-old woman during treatment with piperacillin/tazobactam for a urinary tract infection (UTI).

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics